Neuroscience and Psychiatry

Biography

He is Chief Executive Officer and Chief Medical Officer of ClinFomatrix, USA and Chief Executive Officer of Cure Pharmaceuticals, Inc., USA. He has more than 17 years of experience in drug development, medical affairs and commercialization of cancer drugs including radiopharmaceutical and supportive care; Phase 1 – 4, and marketing commercialization of immuno-oncology, hematology, oncology and radio pharmaceutical drugs in USA, EU and Japan. He is leader in Cancer Drug Development Worldwide Phase 2 and 3 clinical trials in many countries. He contributed to 21-INDs and 7-NDAs of Cancer Drugs and supportive care, acquisition /merger of pharma and drug for more than $300 million. He received his clinical, medical training & worked at renowned medical centers and pharmaceutical institutions worldwide; Walter Reed Army Institute of Research and Medical Center, Daiichi, Sumitomo, Pharmacia, Pfizer, Sopherion Oncology., Eisai Oncology, and Spectrum Pharmaceuticals.

Research Interest

NEUROSCIENCE